20 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
24411477	84	Carbamazepine derivatives with P2X4 receptor-blocking activity.	University of Bonn
20045645	66	Discovery and optimization of RO-85, a novel drug-like, potent, and selective P2X3 receptor antagonist.	Roche Palo Alto
23075067	98	N-substituted phenoxazine and acridone derivatives: structure-activity relationships of potent P2X4 receptor antagonists.	University of Bonn
12213051	207	Purine and pyrimidine (P2) receptors as drug targets.	National Institute of Diabetes
19231180	81	Identification and SAR of novel diaminopyrimidines. Part 1: The discovery of RO-4, a dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.	Roche Palo Alto
19231178	61	Identification and SAR of novel diaminopyrimidines. Part 2: The discovery of RO-51, a potent and selective, dual P2X(3)/P2X(2/3) antagonist for the treatment of pain.	Roche Palo Alto
11462975	50	Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors.	National Institute of Diabetes and Digestive and Kidney Diseases
32345019	134	Discovery and Structure Relationships of Salicylanilide Derivatives as Potent, Non-acidic P2X1 Receptor Antagonists.	University of Bonn
27427902	93	Potent Suppressive Effects of 1-Piperidinylimidazole Based Novel P2X7 Receptor Antagonists on Cancer Cell Migration and Invasion.	Gwangju Institute of Science and Technology (Gist)
30996785	44	Investigation on 2',3'-	University of Camerino
31532206	26	Development of High-Throughput Fluorescent-Based Screens to Accelerate Discovery of P2X Inhibitors from Animal Venoms.	University of East Anglia
31746599	78	Discovery and Characterization of the Potent and Selective P2X4 Inhibitor	Bayer
26460788	45	Novel Series of Dihydropyridinone P2X7 Receptor Antagonists.	Hoffmann-La Roche
29649742	55	Synthesis and structure-activity relationships of quinolinone and quinoline-based P2X7 receptor antagonists and their anti-sphere formation activities in glioblastoma cells.	Gwangju Institute of Science and Technology (Gist)
29805055	40	Pyrrolinone derivatives as a new class of P2X3 receptor antagonists. Part 1: Initial structure-activity relationship studies of a hit from a high throughput screening.	Shionogi
8730754	7	Pharmacological profile of TP-680, a new cholecystokininA receptor antagonist.	University of Occupational and Environmental Health